MedTrace Logo

Pressure Sensing to Reduce the Risk of Pressure Ulcer Formation

NCT02325388 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 678

Last updated 2019-05-16

No results posted yet for this study

Summary

Pressure ulcers are prevalent conditions that result in substantial financial costs to the healthcare system as well as significant distress to affected patients and their families. This study is a parallel two-group randomized controlled trial that aims to study how the use of a pressure sensing device with continuous visual feedback of pressure imaging may potentially decrease the interface pressure of patients who are at risk of pressure ulcers in an acute hospital setting.

Conditions

  • Pressure Ulcer

Interventions

DEVICE

ForeSite PT™ system

XSENSOR Technology Corporation's ForeSite PT™ Patient Turn System (referred to as the "ForeSite PT™ system") continuously monitors interface pressure and provides CPI that quantifies real-time interface pressure information. It also provides patient turn tracking to assist with management of the patient turn schedule by alerting healthcare providers and/or caregivers to the location of body areas that have experienced the greatest exposure, and when the next turn/repositioning is due as per pre-set alerts.

Sponsors & Collaborators

  • Ward of the 21st Century

    collaborator OTHER

  • Alberta Innovates Health Solutions

    collaborator OTHER

  • University of Calgary

    lead OTHER

Principal Investigators

  • Chester H Ho, MD · University of Calgary

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-12-31
Primary Completion
2018-05-07
Completion
2018-05-10

Countries

  • Canada

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02325388 on ClinicalTrials.gov